- Sponsored -
Cake-Defi-728x90Cake-Defi-728x90

Discover Categories

FDA Approves Iterum (ITRM)’s ORLYNVAH™ for Resistant UTIs

Iterum Therapeutics plc (ITRM) has received U.S. FDA approval for ORLYNVAH™ (sulopenem etzadroxil and probenecid), an oral treatment for uncomplicated

- Advertisement -
Ad imageAd image
- Advertisement -
Ad imageAd image